Released Oct 27, 2026, before the open
10-Q filed Oct 27, 2026, 27 days after period end · 0001193125-26-433661
CTS Announces Third Quarter 2026 Results 2026 Outlook Raised on Record Profitability; Millar Acquisition Advances Diversification Lisle, Ill.
The release| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $149.58M | $142.97M | $132.38M | $134.55M |
| Net Income | $17.76M | $13.69M | $18.08M |
CTS Corp · CIK 26058 · Engraved from SEC EDGAR
| $13.97M |
| EPS Diluted | $0.61 | $0.46 | $0.59 | $0.44 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CTS reported third quarter 2026 sales of $149.6 million, up 5% year over year, and net income of $17.8 million, or 11.9% of sales.¶2¶3
CTS raised its 2026 guidance for sales to $580-$590 million from $565-$585 million and adjusted diluted EPS to $2.78-$2.88 from $2.55-$2.70, assuming current market conditions continue.¶4
The company announced the Millar acquisition, which advances its diversification strategy, particularly in the medical end market.¶1¶5